SCHEDULE 13D/A: KKR Boosts Stake in Henry Schein to 12.5% and Secures Board Representation

Private equity giant KKR has increased its beneficial ownership in Henry Schein Inc. to 12.5% and appointed an executive advisor to the company's board of directors.

Summary

• KKR, through various affiliated entities, has increased its aggregate beneficial ownership in Henry Schein Inc. to 15,652,032 shares of Common Stock.
• This represents approximately 12.5% of Henry Schein's outstanding Common Stock.
• The increase in ownership includes 350,166 shares transferred to KKR Hawaii Aggregator L.P. on May 16, 2025, from a swap settlement at an effective purchase price of approximately $77.06 per share.
• Additionally, Henry Schein issued and sold 3,285,152 Private Placement Shares to KKR Hawaii Aggregator L.P. on May 16, 2025, as part of a previously disclosed Investment.
• The funds for these acquisitions came from capital contributions of the Reporting Persons and their respective partners, members, and affiliates.
• William K. "Dan" Daniel, an executive advisor for Kohlberg Kravis Roberts & Co. L.P., was appointed to Henry Schein's Board of Directors, effective May 16, 2025, as a designee of KKR Hawaii Aggregator L.P.
• The calculation of beneficial ownership is based on 121,719,546 shares outstanding as of April 28, 2025, plus the 3,285,152 shares issued in connection with the Investment.

Sentiment

Score: 8

Explanation: The document indicates a significant increase in beneficial ownership by a major investment firm (KKR) and the appointment of their representative to the board, which is generally a strong positive signal of confidence and potential strategic alignment for the company.

Positives

• KKR's increased stake and board appointment signal a strong vote of confidence in Henry Schein's future prospects and strategic direction.
• The appointment of William K. "Dan" Daniel, an executive advisor from KKR, to the board could bring valuable strategic insights and governance oversight to Henry Schein.
• The private placement of shares indicates a direct investment by a major institutional investor, potentially strengthening Henry Schein's capital base.

Future Outlook

The appointment of a KKR executive advisor to Henry Schein's board suggests KKR intends to have ongoing influence over the corporate activities and strategic direction of the Issuer.

Industry Context

This filing highlights a significant investment by Kohlberg Kravis Roberts & Co. L.P. (KKR), a leading global investment firm, into Henry Schein Inc., a prominent distributor of healthcare products and services. KKR's increased stake and board representation indicate a strategic interest in the healthcare distribution sector, potentially signaling confidence in Henry Schein's market position and growth opportunities within the broader healthcare industry.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: The issuance of new shares in the private placement could result in minor dilution for existing shareholders, but the increased institutional ownership by KKR may also be viewed positively, potentially stabilizing or boosting investor confidence.
• Management: The addition of a KKR representative to the board introduces a new voice and perspective, potentially influencing strategic decisions and corporate governance.

Next Steps

• William K. "Dan" Daniel, as a board director, may influence the corporate activities of Henry Schein Inc.

Key Dates

Keywords

Henry Schein, KKR, Kohlberg Kravis Roberts, Schedule 13D, Beneficial Ownership, Board of Directors, Private Placement, Equity Investment, Healthcare Distribution, Dental Supply, Medical Supply